GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Asset Impairment Charge

Indo-Bangla Pharmaceuticals (DHA:IBP) Asset Impairment Charge : BDT0.00 Mil (TTM As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals Asset Impairment Charge?

Indo-Bangla Pharmaceuticals's Asset Impairment Charge for the six months ended in . 20 was BDT0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Asset Impairment Charge Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals Asset Impairment Charge Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Asset Impairment Charge

Indo-Bangla Pharmaceuticals Semi-Annual Data
Asset Impairment Charge

Indo-Bangla Pharmaceuticals Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Asset Impairment Charge
Comparable Companies
Traded in Other Exchanges
N/A
Address
Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Website
http://www.indo-banglapharma.com
Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.